학술논문
전자자료 공정이용 안내
우리 대학 도서관에서 구독·제공하는 모든 전자자료(데이터베이스, 전자저널, 전자책 등)는 국내외 저작권법과 출판사와의 라이선스 계약에 따라 엄격하게 보호를 받고 있습니다.
전자자료의 비정상적 이용은 출판사로부터의 경고, 서비스 차단, 손해배상 청구 등 학교 전체에 심각한 불이익을 초래할 수 있으므로, 아래의 공정이용 지침을 반드시 준수해 주시기 바랍니다.
공정이용 지침
- 전자자료는 개인의 학습·교육·연구 목적의 비영리적 사용에 한하여 이용할 수 있습니다.
- 합리적인 수준의 다운로드 및 출력만 허용됩니다. (일반적으로 동일 PC에서 동일 출판사의 논문을 1일 30건 이하 다운로드할 것을 권장하며, 출판사별 기준에 따라 다를 수 있습니다.)
- 출판사에서 제공한 논문의 URL을 수업 관련 웹사이트에 게재할 수 있으나, 출판사 원문 파일 자체를 복제·배포해서는 안 됩니다.
- 본인의 ID/PW를 타인에게 제공하지 말고, 도용되지 않도록 철저히 관리해 주시기 바랍니다.
불공정 이용 사례
- 전자적·기계적 수단(다운로딩 프로그램, 웹 크롤러, 로봇, 매크로, RPA 등)을 이용한 대량 다운로드
- 동일 컴퓨터 또는 동일 IP에서 단시간 내 다수의 원문을 집중적으로 다운로드하거나, 전권(whole issue) 다운로드
- 저장·출력한 자료를 타인에게 배포하거나 개인 블로그·웹하드 등에 업로드
- 상업적·영리적 목적으로 자료를 전송·복제·활용
- ID/PW를 타인에게 양도하거나 타인 계정을 도용하여 이용
- EndNote, Mendeley 등 서지관리 프로그램의 Find Full Text 기능을 이용한 대량 다운로드
- 출판사 콘텐츠를 생성형 AI 시스템에서 활용하는 행위(업로드, 개발, 학습, 프로그래밍, 개선 또는 강화 등)
위반 시 제재
- 출판사에 의한 해당 IP 또는 기관 전체 접속 차단
- 출판사 배상 요구 시 위반자 개인이 배상 책임 부담
'학술논문'
에서 검색결과 189건 | 목록
1~20
Academic Journal
Journal of Geriatric Oncology. 16(8)
Academic Journal
Kilikova K; Department of Oncology, Faculty Hospital, Trnava, Slovakia.; Mlcakova A; Department of Medical Oncology, National Cancer Institute, Bratislava, Slovakia.; Sestakova Z; Flow cytometry Laboratory, Department of Laboratory Medicine, National Institute of Children's Diseases, Bratislava, Slovakia.; Kalavska K; 2nd Department of Oncology, Faculty of Medicine, Comenius University & National Cancer Institute, Bratislava, Slovakia.; Translational Research Unit, 2nd Department of Oncology, Faculty of Medicine, Comenius University & National Cancer Institute, Bratislava, Slovakia.; Adamikova K; 2nd Department of Oncology, Faculty of Medicine, Comenius University & National Cancer Institute, Bratislava, Slovakia.; Obertova J; Department of Medical Oncology, National Cancer Institute, Bratislava, Slovakia.; 2nd Department of Oncology, Faculty of Medicine, Comenius University & National Cancer Institute, Bratislava, Slovakia.; Palacka P; Department of Medical Oncology, National Cancer Institute, Bratislava, Slovakia.; 2nd Department of Oncology, Faculty of Medicine, Comenius University & National Cancer Institute, Bratislava, Slovakia.; Cancer Research Institute, Biomedical Research Center, Slovak Academy of Sciences, , Bratislava, Slovakia.; Rejlekova K; Department of Medical Oncology, National Cancer Institute, Bratislava, Slovakia.; 2nd Department of Oncology, Faculty of Medicine, Comenius University & National Cancer Institute, Bratislava, Slovakia.; Sycova-Mila Z; Department of Medical Oncology, National Cancer Institute, Bratislava, Slovakia.; De Angelis V; Department of Medical Oncology, National Cancer Institute, Bratislava, Slovakia.; Orszaghova Z; Department of Medical Oncology, National Cancer Institute, Bratislava, Slovakia.; 2nd Department of Oncology, Faculty of Medicine, Comenius University & National Cancer Institute, Bratislava, Slovakia.; Lesko P; 2nd Department of Oncology, Faculty of Medicine, Comenius University & National Cancer Institute, Bratislava, Slovakia.; Svetlovska D; 2nd Department of Oncology, Faculty of Medicine, Comenius University & National Cancer Institute, Bratislava, Slovakia.; Mladosievicova B; Institute of Pathological Physiology, Faculty of Medicine, Comenius University, Bratislava, Slovakia.; Cheng L; Department of Pathology and Laboratory Medicine Brown University Warren Alpert Medical School, the Legorreta Cancer Center at Brown University, and Brown University Health, Providence, RI, United States.; Department of Surgery (Urology), Brown University Warren Alpert Medical School, the Legorreta Cancer Center at Brown University, and Brown University Health, Providence, RI, United States.; Mego M; Department of Medical Oncology, National Cancer Institute, Bratislava, Slovakia.; 2nd Department of Oncology, Faculty of Medicine, Comenius University & National Cancer Institute, Bratislava, Slovakia.; Translational Research Unit, 2nd Department of Oncology, Faculty of Medicine, Comenius University & National Cancer Institute, Bratislava, Slovakia.; Chovanec M; Department of Medical Oncology, National Cancer Institute, Bratislava, Slovakia.; 2nd Department of Oncology, Faculty of Medicine, Comenius University & National Cancer Institute, Bratislava, Slovakia.; Cancer Research Institute, Biomedical Research Center, Slovak Academy of Sciences, , Bratislava, Slovakia.
Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet ISSN: 1664-3224 (Electronic) Linking ISSN: 16643224 NLM ISO Abbreviation: Front Immunol Subsets: MEDLINE
Academic Journal
M, Mego; D, Svetlovska; De, Angelis V; K, Kalavska; P, Lesko; M, Makovník; J, Obertova; Z, Orszaghova; P, Palacka; M, Rečková; K, Rejlekova; Sycova-Mila, Z; J, Mardiak; M, Chovanec
Investigational New Drugs. 40:1080-1086
Academic Journal
M, Mego; D, Svetlovska; M, Reckova; De, Angelis; K, Kalavska; J, Obertova; P, Palacka; K, Rejlekova; Z, Sycova-Mila; M, Chovanec; J, Mardiak
Investigational New Drugs. 39:1664-1670
Academic Journal
Tomčová Z; 2nd Department of Oncology, Faculty of Medicine, Comenius University and National Cancer Institute, Klenová 1, 833 10 Bratislava, Slovakia.; Department of Oncology, University General Hospital, Špitálska 6, 950 01 Nitra, Slovakia.; Obertová J; 2nd Department of Oncology, Faculty of Medicine, Comenius University and National Cancer Institute, Klenová 1, 833 10 Bratislava, Slovakia.; Chovanec M; 2nd Department of Oncology, Faculty of Medicine, Comenius University and National Cancer Institute, Klenová 1, 833 10 Bratislava, Slovakia.; Cancer Research Institute, Biomedical Research Center, Slovak Academy of Sciences, Dúbravská cesta 9, 814 39 Bratislava, Slovakia.; Syčová-Milá Z; 2nd Department of Oncology, Faculty of Medicine, Comenius University and National Cancer Institute, Klenová 1, 833 10 Bratislava, Slovakia.; Štefániková K; Department of Oncology, East Slovak Cancer Institute, Rastislavova 43, 041 91 Košice, Slovakia.; Šlachtová E; Department of Oncology, East Slovak Cancer Institute, Rastislavova 43, 041 91 Košice, Slovakia.; Žák M; Department of Oncology, East Slovak Cancer Institute, Rastislavova 43, 041 91 Košice, Slovakia.; Savka A; Department of Oncology, F. D. Roosevelt University General Hospital, Nám. Ľ. Svobodu 1, 975 17 Banská Bystrica, Slovakia.; Hrnčár M; Department of Oncology, F. D. Roosevelt University General Hospital, Nám. Ľ. Svobodu 1, 975 17 Banská Bystrica, Slovakia.; Rejleková K; 2nd Department of Oncology, Faculty of Medicine, Comenius University and National Cancer Institute, Klenová 1, 833 10 Bratislava, Slovakia.; Palacka P; 2nd Department of Oncology, Faculty of Medicine, Comenius University and National Cancer Institute, Klenová 1, 833 10 Bratislava, Slovakia.; Cancer Research Institute, Biomedical Research Center, Slovak Academy of Sciences, Dúbravská cesta 9, 814 39 Bratislava, Slovakia.
Publisher: MDPI AG Country of Publication: Switzerland NLM ID: 101691304 Publication Model: Electronic Cited Medium: Print ISSN: 2227-9059 (Print) Linking ISSN: 22279059 NLM ISO Abbreviation: Biomedicines Subsets: PubMed not MEDLINE
Academic Journal
M, Mego; D, Svetlovska; M, Chovanec; M, Rečkova; K, Rejlekova; J, Obertova; P, Palacka; Z, Sycova-Mila; U, De Giorgi; J, Mardiak
Investigational New Drugs. 37:748-754
Academic Journal
M. Chovanec; L. Vasilkova; L. Petrikova; J. Obertova; P. Palacka; K. Rejlekova; Z. Sycova-Mila; K. Kalavska; D. Svetlovska; B. Mladosievicova; J. Mardiak; M. Mego
BMC Cancer, Vol 20, Iss 1, Pp 1-10 (2020)
Academic Journal
Orszaghova Z; 2nd Department of Oncology, Comenius University and National Cancer Institute, Bratislava, Slovakia.; Svetlovska D; Translational Research Unit, 2nd Department of Oncology, Comenius University and National Cancer Institute, Bratislava, Slovakia.; Vasilkova L; 2nd Department of Oncology, Comenius University and National Cancer Institute, Bratislava, Slovakia.; Lesko P; 2nd Department of Oncology, Comenius University and National Cancer Institute, Bratislava, Slovakia.; Sycova-Mila Z; 2nd Department of Oncology, Comenius University and National Cancer Institute, Bratislava, Slovakia.; Obertova J; 2nd Department of Oncology, Comenius University and National Cancer Institute, Bratislava, Slovakia.; Palacka P; 2nd Department of Oncology, Comenius University and National Cancer Institute, Bratislava, Slovakia.; Rejlekova K; 2nd Department of Oncology, Comenius University and National Cancer Institute, Bratislava, Slovakia.; Remenarova V; 2nd Department of Oncology, Comenius University and National Cancer Institute, Bratislava, Slovakia.; Kalavska K; Translational Research Unit, 2nd Department of Oncology, Comenius University and National Cancer Institute, Bratislava, Slovakia.; Mladosievicova B; Department of Clinical Pathophysiology, Comenius University, Bratislava, Slovakia.; Mardiak J; 2nd Department of Oncology, Comenius University and National Cancer Institute, Bratislava, Slovakia.; Mego M; 2nd Department of Oncology, Comenius University and National Cancer Institute, Bratislava, Slovakia.; Chovanec M; 2nd Department of Oncology, Comenius University and National Cancer Institute, Bratislava, Slovakia; Cancer Research Institute, Biomedical Research Center, Slovak Academy of Sciences, Bratislava, Slovakia. Electronic address: michal.chovanec1@gmail.com.
Publisher: Elsevier B.V Country of Publication: Netherlands NLM ID: 101724904 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2588-9311 (Electronic) Linking ISSN: 25889311 NLM ISO Abbreviation: Eur Urol Oncol Subsets: MEDLINE
Academic Journal
Lesko P; 2nd Department of Oncology, Faculty of Medicine, Comenius University and National Cancer Institute, Bratislava, Slovakia.; Vlkova B; Institute of Molecular Biomedicine, Faculty of Medicine, Comenius University, Bratislava, Slovakia.; Kalavska K; Translation Research Unit, Comenius University, National Cancer Institute, Bratislava, Slovakia.; De Angelis V; 2nd Department of Oncology, Faculty of Medicine, Comenius University and National Cancer Institute, Bratislava, Slovakia.; Novotna V; 1st Department of Oncology, Faculty of Medicine Comenius University (FMCU) and St. Elizabeth Cancer Institute, Bratislava, Slovakia.; Obertova J; 2nd Department of Oncology, Faculty of Medicine, Comenius University and National Cancer Institute, Bratislava, Slovakia.; Orszaghova Z; 2nd Department of Oncology, Faculty of Medicine, Comenius University and National Cancer Institute, Bratislava, Slovakia.; Palacka P; 2nd Department of Oncology, Faculty of Medicine, Comenius University and National Cancer Institute, Bratislava, Slovakia.; Rejlekova K; 2nd Department of Oncology, Faculty of Medicine, Comenius University and National Cancer Institute, Bratislava, Slovakia.; Sycova-Mila Z; 2nd Department of Oncology, Faculty of Medicine, Comenius University and National Cancer Institute, Bratislava, Slovakia.; Kollarik B; 2nd Department of Oncology, Faculty of Medicine, Comenius University and National Cancer Institute, Bratislava, Slovakia.; Aziri R; Department of Surgical Oncology, National Institute for Oncology, Bratislava, Slovakia.; Pindak D; Department of Surgical Oncology, National Institute for Oncology, Bratislava, Slovakia.; Mardiak J; 2nd Department of Oncology, Faculty of Medicine, Comenius University and National Cancer Institute, Bratislava, Slovakia.; Chovanec M; 2nd Department of Oncology, Faculty of Medicine, Comenius University and National Cancer Institute, Bratislava, Slovakia.; Celec P; Institute of Molecular Biomedicine, Faculty of Medicine, Comenius University, Bratislava, Slovakia.; Mego M; Translation Research Unit, Comenius University, National Cancer Institute, Bratislava, Slovakia.
Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101568867 Publication Model: eCollection Cited Medium: Print ISSN: 2234-943X (Print) Linking ISSN: 2234943X NLM ISO Abbreviation: Front Oncol Subsets: PubMed not MEDLINE
Academic Journal
Chovanec M; 2nd Department of Oncology, Faculty of Medicine, Comenius University and National Cancer Institute, Bratislava, Slovakia.; Department of Medical Oncology, National Cancer Institute, Bratislava, Slovakia.; Kalavska K; 2nd Department of Oncology, Faculty of Medicine, Comenius University and National Cancer Institute, Bratislava, Slovakia.; Translational Research Unit, 2nd Department of Oncology, Faculty of Medicine, Comenius University and National Cancer Institute, Bratislava, Slovakia.; Obertova J; 2nd Department of Oncology, Faculty of Medicine, Comenius University and National Cancer Institute, Bratislava, Slovakia.; Department of Medical Oncology, National Cancer Institute, Bratislava, Slovakia.; Palacka P; 2nd Department of Oncology, Faculty of Medicine, Comenius University and National Cancer Institute, Bratislava, Slovakia.; Department of Medical Oncology, National Cancer Institute, Bratislava, Slovakia.; Rejlekova K; 2nd Department of Oncology, Faculty of Medicine, Comenius University and National Cancer Institute, Bratislava, Slovakia.; Department of Medical Oncology, National Cancer Institute, Bratislava, Slovakia.; Sycova-Mila Z; Department of Medical Oncology, National Cancer Institute, Bratislava, Slovakia.; Orszaghova Z; 2nd Department of Oncology, Faculty of Medicine, Comenius University and National Cancer Institute, Bratislava, Slovakia.; Department of Medical Oncology, National Cancer Institute, Bratislava, Slovakia.; Lesko P; 2nd Department of Oncology, Faculty of Medicine, Comenius University and National Cancer Institute, Bratislava, Slovakia.; Department of Medical Oncology, National Cancer Institute, Bratislava, Slovakia.; De Angelis V; Department of Medical Oncology, National Cancer Institute, Bratislava, Slovakia.; Vasilkova L; Department of Psychology, Faculty of Philosophy, Comenius University, Bratislava, Slovakia.; Svetlovska D; Department of Clinical Trials, National Cancer Institute, Bratislava, Slovakia.; Mladosievicova B; Institute of Pathological Physiology, Faculty of Medicine, Comenius University, Bratislava, Slovakia.; Mardiak J; 2nd Department of Oncology, Faculty of Medicine, Comenius University and National Cancer Institute, Bratislava, Slovakia.; Department of Medical Oncology, National Cancer Institute, Bratislava, Slovakia.; Pastorek M; Institute of Molecular Biomedicine, Faculty of Medicine, Comenius University, Bratislava, Slovakia.; Vlkova B; Institute of Molecular Biomedicine, Faculty of Medicine, Comenius University, Bratislava, Slovakia.; Celec P; Institute of Pathological Physiology, Faculty of Medicine, Comenius University, Bratislava, Slovakia.; Institute of Molecular Biomedicine, Faculty of Medicine, Comenius University, Bratislava, Slovakia.; Mego M; 2nd Department of Oncology, Faculty of Medicine, Comenius University and National Cancer Institute, Bratislava, Slovakia.; Department of Medical Oncology, National Cancer Institute, Bratislava, Slovakia.; Translational Research Unit, 2nd Department of Oncology, Faculty of Medicine, Comenius University and National Cancer Institute, Bratislava, Slovakia.
Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101568867 Publication Model: eCollection Cited Medium: Print ISSN: 2234-943X (Print) Linking ISSN: 2234943X NLM ISO Abbreviation: Front Oncol Subsets: PubMed not MEDLINE
Academic Journal
Klinicka onkologie. 27:429-433
Academic Journal
Neoplasma. 56:398-403
Academic Journal
Neoplasma. 56:215-223
Academic Journal
Klinicka Onkologie. 31
Academic Journal
Kalavska K; Translational Research Unit, Faculty of Medicine, National Cancer Institute, Comenius University, Bratislava, Slovakia.; Department of Molecular Oncology, Cancer Research Institute, Biomedical Research Center, Slovak Academy of Sciences, Bratislava, Slovakia.; Sestakova Z; Department of Genetics, Cancer Research Institute, Biomedical Research Center, Slovak Academy of Sciences, Bratislava, Slovakia.; Department of Laboratory Medicine, National Institute of Children's Diseases, Bratislava, Slovakia.; Mlcakova A; Department of Hematology, National Cancer Institute, Bratislava, Slovakia.; Gronesova P; Department of Tumor Immunology, Cancer Research Institute, Biomedical Research Center, Slovak Academy of Sciences, Bratislava, Slovakia.; Miskovska V; 1stDepartment of Oncology, Faculty of Medicine, St. Elisabeth Cancer Institute, Comenius University, Bratislava, Slovakia.; Rejlekova K; 2ndDepartment of Oncology, Faculty of Medicine, National Cancer Institute, Comenius University, Bratislava, Slovakia.; Department of Oncology, National Cancer Institute, Bratislava, Slovakia.; Svetlovska D; Translational Research Unit, Faculty of Medicine, National Cancer Institute, Comenius University, Bratislava, Slovakia.; Sycova-Mila Z; Department of Oncology, National Cancer Institute, Bratislava, Slovakia.; Obertova J; 2ndDepartment of Oncology, Faculty of Medicine, National Cancer Institute, Comenius University, Bratislava, Slovakia.; Department of Oncology, National Cancer Institute, Bratislava, Slovakia.; Palacka P; 2ndDepartment of Oncology, Faculty of Medicine, National Cancer Institute, Comenius University, Bratislava, Slovakia.; Department of Oncology, National Cancer Institute, Bratislava, Slovakia.; Mardiak J; 2ndDepartment of Oncology, Faculty of Medicine, National Cancer Institute, Comenius University, Bratislava, Slovakia.; Department of Oncology, National Cancer Institute, Bratislava, Slovakia.; Chovanec M; Department of Genetics, Cancer Research Institute, Biomedical Research Center, Slovak Academy of Sciences, Bratislava, Slovakia.; Chovanec M; 2ndDepartment of Oncology, Faculty of Medicine, National Cancer Institute, Comenius University, Bratislava, Slovakia.; Department of Oncology, National Cancer Institute, Bratislava, Slovakia.; Mego M; Translational Research Unit, Faculty of Medicine, National Cancer Institute, Comenius University, Bratislava, Slovakia.; Department of Genetics, Cancer Research Institute, Biomedical Research Center, Slovak Academy of Sciences, Bratislava, Slovakia.; 2ndDepartment of Oncology, Faculty of Medicine, National Cancer Institute, Comenius University, Bratislava, Slovakia.; Department of Oncology, National Cancer Institute, Bratislava, Slovakia.
Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101568867 Publication Model: eCollection Cited Medium: Print ISSN: 2234-943X (Print) Linking ISSN: 2234943X NLM ISO Abbreviation: Front Oncol Subsets: PubMed not MEDLINE
Academic Journal
Orszaghova Z; Department of Oncology, Comenius University, Faculty of Medicine and National Cancer Institute, Bratislava, Slovakia.; Galikova D; Department of Oncology, Comenius University, Faculty of Medicine and National Cancer Institute, Bratislava, Slovakia.; Lesko P; Department of Oncology, Comenius University, Faculty of Medicine and National Cancer Institute, Bratislava, Slovakia.; Obertova J; Department of Oncology, Comenius University, Faculty of Medicine and National Cancer Institute, Bratislava, Slovakia.; Rejlekova K; Department of Oncology, Comenius University, Faculty of Medicine and National Cancer Institute, Bratislava, Slovakia.; Sycova-Mila Z; Department of Oncology, Comenius University, Faculty of Medicine and National Cancer Institute, Bratislava, Slovakia.; Palacka P; Department of Oncology, Comenius University, Faculty of Medicine and National Cancer Institute, Bratislava, Slovakia.; Kalavska K; Translational Research Unit, Department of Oncology, Comenius University, Faculty of Medicine and National Cancer Institute, Bratislava, Slovakia.; Svetlovska D; Translational Research Unit, Department of Oncology, Comenius University, Faculty of Medicine and National Cancer Institute, Bratislava, Slovakia.; Mladosievicova B; Department of Clinical Pathophysiology, Comenius University, Faculty of Medicine, Bratislava, Slovakia.; Mardiak J; Department of Oncology, Comenius University, Faculty of Medicine and National Cancer Institute, Bratislava, Slovakia.; Mego M; Department of Oncology, Comenius University, Faculty of Medicine and National Cancer Institute, Bratislava, Slovakia.; Chovanec M; Department of Oncology, Comenius University, Faculty of Medicine and National Cancer Institute, Bratislava, Slovakia. Electronic address: michal.chovanec1@gmail.com.
Publisher: Elsevier Country of Publication: United States NLM ID: 101260955 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1938-0682 (Electronic) Linking ISSN: 15587673 NLM ISO Abbreviation: Clin Genitourin Cancer Subsets: MEDLINE
Academic Journal
Rejlekova K; 2nd Department of Oncology, Faculty of Medicine, Comenius University and National Cancer Institute, Bratislava, Slovakia.; Oncology Department, National Cancer Institute, Bratislava, Slovakia.; Kalavska K; 2nd Department of Oncology, Faculty of Medicine, Comenius University and National Cancer Institute, Bratislava, Slovakia.; Oncology Department, National Cancer Institute, Bratislava, Slovakia.; Translational Research Unit, Faculty of Medicine, Comenius University, National Cancer Institute, Bratislava, Slovakia.; Makovnik M; 2nd Department of Oncology, Faculty of Medicine, Comenius University and National Cancer Institute, Bratislava, Slovakia.; Radiology Department, National Cancer Institute, Bratislava, Slovakia.; Hapakova N; 2nd Department of Oncology, Faculty of Medicine, Comenius University and National Cancer Institute, Bratislava, Slovakia.; Oncology Department, National Cancer Institute, Bratislava, Slovakia.; Chovanec M; 2nd Department of Oncology, Faculty of Medicine, Comenius University and National Cancer Institute, Bratislava, Slovakia.; Oncology Department, National Cancer Institute, Bratislava, Slovakia.; De Angelis V; Oncology Department, National Cancer Institute, Bratislava, Slovakia.; Obertova J; 2nd Department of Oncology, Faculty of Medicine, Comenius University and National Cancer Institute, Bratislava, Slovakia.; Oncology Department, National Cancer Institute, Bratislava, Slovakia.; Palacka P; 2nd Department of Oncology, Faculty of Medicine, Comenius University and National Cancer Institute, Bratislava, Slovakia.; Oncology Department, National Cancer Institute, Bratislava, Slovakia.; Sycova-Mila Z; Oncology Department, National Cancer Institute, Bratislava, Slovakia.; Mardiak J; 2nd Department of Oncology, Faculty of Medicine, Comenius University and National Cancer Institute, Bratislava, Slovakia.; Oncology Department, National Cancer Institute, Bratislava, Slovakia.; Mego M; 2nd Department of Oncology, Faculty of Medicine, Comenius University and National Cancer Institute, Bratislava, Slovakia.; Oncology Department, National Cancer Institute, Bratislava, Slovakia.; Translational Research Unit, Faculty of Medicine, Comenius University, National Cancer Institute, Bratislava, Slovakia.
Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101568867 Publication Model: eCollection Cited Medium: Print ISSN: 2234-943X (Print) Linking ISSN: 2234943X NLM ISO Abbreviation: Front Oncol Subsets: PubMed not MEDLINE
Academic Journal
M. Mego; D. Svetlovska; K. Rejlekova; V. Miskovska; V. De Angelis; K. Kalavska; J. Obertova; P. Palacka; Z. Sycova-Mila; M. Chovanec; J. Mardiak
Annals of Oncology. 31:S600
Academic Journal
Hapakova N; 2nd Department of Oncology, Comenius University, Faculty of Medicine, National Cancer Institute, Bratislava, Slovakia.; Chovanec M; 2nd Department of Oncology, Comenius University, Faculty of Medicine, National Cancer Institute, Bratislava, Slovakia.; Rejlekova K; 2nd Department of Oncology, Comenius University, Faculty of Medicine, National Cancer Institute, Bratislava, Slovakia.; Kalavska K; 2nd Department of Oncology, Comenius University, Faculty of Medicine, National Cancer Institute, Bratislava, Slovakia.; Obertova J; 2nd Department of Oncology, Comenius University, Faculty of Medicine, National Cancer Institute, Bratislava, Slovakia.; Palacka P; 2nd Department of Oncology, Comenius University, Faculty of Medicine, National Cancer Institute, Bratislava, Slovakia.; De Angelis V; 2nd Department of Oncology, Comenius University, Faculty of Medicine, National Cancer Institute, Bratislava, Slovakia.; Sycova-Mila Z; 2nd Department of Oncology, Comenius University, Faculty of Medicine, National Cancer Institute, Bratislava, Slovakia.; Mardiak J; 2nd Department of Oncology, Comenius University, Faculty of Medicine, National Cancer Institute, Bratislava, Slovakia.; Mego M; 2nd Department of Oncology, Comenius University, Faculty of Medicine, National Cancer Institute, Bratislava, Slovakia.
Publisher: AEPress Country of Publication: Slovakia NLM ID: 0377266 Publication Model: Print-Electronic Cited Medium: Print ISSN: 0028-2685 (Print) Linking ISSN: 00282685 NLM ISO Abbreviation: Neoplasma Subsets: MEDLINE
Academic Journal
Mego, M; Svetlovska, D; Angelis V, De; Kalavska, K; Lesko, P; Makovník, M; Obertova, J; Orszaghova, Z; Palacka, P; Rečková, M; Rejlekova, K; Z, Sycova-Mila; Mardiak, J; Chovanec, M
검색 결과 제한하기
제한된 항목
[검색어] Sycova-Mila, Z.
발행연도 제한
-
학술DB(Database Provider)
저널명(출판물, Title)
출판사(Publisher)
자료유형(Source Type)
주제어
언어